I-Mab appointed Raj Kannan as the new CEO and a member of the board of directors effective June 22. Raj Kannan has over 30 years of industry experience as a biotech CEO, more recently as CEO of Aerie Pharmaceuticals, and before that of Chiasma Pharmaceuticals.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on IMAB:
